DEC 20, 2017 7:20 AM PST

Experimental Vaccine Created to Tackle the Opioid Crisis

WRITTEN BY: Kara Marker

A new treatment option for heroin and other opioid misuse diminishes the effects of the drugs, providing new potential to prevent overdoses and help individuals overcome addictions. The experimental vaccine comes from scientists at the The U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research (WRAIR).

Dr. Gary Matyas' lab at the Walter Reed Army Institute of Research. Credit: MHRP

The vaccine works by activating antibodies that prevent misused opioids from crossing the blood-brain barrier (BBB), a diffusion barrier that protects the brain from being exposed to things like drugs in the blood. In addition to heroin, misuse of opioids like hydrocodone, oxycodone, and codeine are contributing to a growing opioid epidemic in the United States, as the Centers for Disease Control and Prevention estimates that 91 Americans die every day of an opioid overdose.

Researchers tested the experimental vaccine in rats and mice, in their new study published in the Journal of Medicinal Chemistry. It contains drugs that stimulate the immune system, an adjuvant called the “Army Liposome Formulation” (ALF).

“The vaccine aims to block the euphoria and addictive effects,” explained MHRP’s Dr. Gary Matyas. “This study suggests that vaccination can be used together with standard therapies to prevent the withdrawal and craving symptoms associated with opioid withdrawal."

Before Matyas and others could confirm the vaccine’s potential to be used with other therapies, they had to ensure that the antibodies activated by the vaccine would not cross-react with other drugs used for opioid misuse, including methadone, buprenorphine, and naltrexone. They found that antibodies induced by the new experimental vaccine do not react with these drugs or with a drug called naloxone, which is used as an “overdose rescue” treatment.

Overdose rescue treatment reverses the effects of hypoventilation, or respiratory depression. Hypoventilation is characterized by slow and ineffective breathing caused by the body’s inability to effectively remove carbon dioxide to make room for oxygen; hypoventilation can lead to confusion, headache, and seizures.

The new study also found that the vaccine has no reaction with non-narcotic pain relievers, including aspirin, ibuprofen and acetaminophen.

Researchers involved with the study are hopeful that further studies of the experimental opioid vaccine will eventually improve access to and success of treatment for opioid management therapy, which is often not available and is associated with high relapse rates even when it is accessible.

Sources: Healthline, Neurobiology of Disease, The U.S. Military HIV Research Program

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
DEC 27, 2020
Immunology
Thymus Transplantation?! It Could be Possible!
DEC 27, 2020
Thymus Transplantation?! It Could be Possible!
The thymus is an essential organ of the lymphatic system; it is responsible for developing mature T cells. T c ...
APR 06, 2021
Immunology
Lymphoma Patient Cured by "Reeducating" their Immune System
APR 06, 2021
Lymphoma Patient Cured by "Reeducating" their Immune System
Australian researchers have used a breakthrough therapy to cure a patient diagnosed with a rare brain lymphoma, a form o ...
APR 15, 2021
Immunology
COVID Vaccines Protect Breastfeeding Babies Too
APR 15, 2021
COVID Vaccines Protect Breastfeeding Babies Too
Good news for families of newborns: A new study shows that breastfeeding mothers who receive a COVID vaccine share prote ...
APR 21, 2021
Immunology
Human T Cells Can't Recognize COVID Mutants
APR 21, 2021
Human T Cells Can't Recognize COVID Mutants
Genetic variants of the SARS-CoV-2 virus have emerged and tightened their grip on global communities as the pandemic rag ...
MAY 13, 2021
Immunology
Salmonella Vaccine Uses "Molecular Telephones" to Talk to the Immune System
MAY 13, 2021
Salmonella Vaccine Uses "Molecular Telephones" to Talk to the Immune System
Salmonella infections are a massive problem—Over 95 million people are affected by this foodborne illness every ye ...
MAY 17, 2021
Cell & Molecular Biology
Survey Results: Where Is Pluripotent Stem Cell Research Now?
MAY 17, 2021
Survey Results: Where Is Pluripotent Stem Cell Research Now?
Human pluripotent stem cell (hPSC) lines are now commonly used across the globe. In the lab, researchers rely on hPSCs t ...
Loading Comments...